Menu Back toSession-0704-Development-of-Biosimilars-in-China-Interpretation-of-Biosimilar-Guidance-Opportunities-and-Challenges-II

The 7th DIA China Annual Meeting

Session 0704 Development of Biosimilars in China: Interpretation of Biosimilar Guidance, Opportunities and Challenges - II

Session Chair(s)

Joe  Zhang

Joe Zhang

  • Co-founder and CEO
  • BJ Bioscience Inc., China

Science Based BiosimilarRegulatory Pathway


Weidong  Jiang

Weidong Jiang

  • Chief Strategy Officer and Senior Vice President
  • Henlius, China
Irene  Deng

Science Based BiosimilarRegulatory Pathway

Irene Deng

  • Head of Regulatory Affairs, China
  • Sanofi, China
Cindy  Xu

Cindy Xu

  • Henlius, China

Contact us

For exhibition, advertising and hosting inquiry, please contact:
Jean XU:, or Sofie Peeters:
Tel: +86 10 5923 1096

For general inquiry, please contact DIA China office:
Tel: +86 10 5704 2650